by The global implantable medical device market size is forecasted to reach from US$ 90.5 billion in 2021 to US$ 145.6 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 7% from 2022 to 2030, as per reports by market research and consulting organization Precedence Research.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2022 to 2030. The implantable medical device market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1430
The technological advancements in the healthcare industry has allowed the people to improve their looks and enhance their beauty by implanting medical devices such as dental implants, breast implants, pectoral implants, deltoid implants, and cochlear implants. The rising concerns regarding the aesthetics and physical appearances among the population is another factor that drives the demand for the implantable medical devices. Moreover, the presence of numerous market players and various developmental strategies adopted by them plays a prominent role in influencing the market. Furthermore, the rising number of accident cases in which limbs or organs are damaged is a major factors that may drive the demand for the implantable medical devices across the globe. All these factors are expected to drive the growth of the global implantable medical devices market during the forecast period.
Report Scope of Implantable Medical Devices Market
| Report Coverage | Details |
| Market Size in 2021 | USD 90.5 Billion |
| Growth Rate From 2021 to 2030 | CAGR of 7% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Biomaterial, Region |
Competitive Landscape Analysis:
Some of the leading companies operating in the implantable medical device market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.
Major companies operating in this report are
- Abbott Laboratories
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- C. R. Bard, Inc.
- Cardinal Health, Inc.
- CONMED Corporation
- Globus Medical, Inc.
- Integra Lifesciences Holdings Corporation
- Johnson & Johnson
- LivaNova PLC
- Medtronic plc
- NuVasive, Inc.
- Smith & Nephew plc
- St. Jude Medical, Inc.
- InstitutStraumann AG
Market Overview
Owing to the increasing number of diseases and disorders there has been an upsurge in the demand for implantable medical devices. These devices serve the purpose of supporting or replacement of any damaged body organs, and enhancing, and treating the functioning of normal body functions. An implantable medical device is one of the important components of patient care.
The growing elderly population is one of the critical elements of globally active implantable medical devices market growth. With age, there is a gradual decline in the functioning of various parts of the human body. Thus, human has to rely on various medical devices for mobility and other assistance. This creates demand for implantable products. Some of the chronic diseases that affect adults include heart disease, arthritis, among others. Osteoarthritis (OA) is one of the most common joint disorders in the United States. Also called degenerative joint disease, it occurs most frequently in the hands, hips, and knees. Thus, with the expanding aging population, the demand for Orthopedic Implants and Reconstructive Joint Replacement is expected to increase in the country. With the rising prevalence of cardiovascular diseases demands for active implantable devices, including cardiovascular implants, is expected to increase, in both developed and developing countries.
The concerns related to the devices such as device failure and network security are likely to hamper the market growth. For instance, the device introduced in the human body may bring out an immune response from the surrounding tissues and resulting performance degradation makes it difficult to use these devices for a long period.
Segments Covered in the Report
By Product Type
- Cardiovascular Implants
- Orthopedic Implants
- Intraocular Lens
- Spinal Implants
- Dental Implants
- Others
By Biomaterial
- Ceramic
- Metallic
- Polymers
- Natural
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Why should you invest in this report?
If you are aiming to enter the global implantable medical device market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for implantable medical device are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1430
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Implantable Medical Devices Market
5.1. COVID-19 Landscape: Implantable Medical Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Implantable Medical Devices Market, By Product
8.1. Implantable Medical Devices Market, by Product Type, 2021-2030
8.1.1. Cardiovascular Implants
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Orthopedic Implants
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Intraocular Lens
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Spinal Implants
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Dental Implants
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Implantable Medical Devices Market, By Biomaterial
9.1. Implantable Medical Devices Market, by Biomaterial, 2021-2030
9.1.1. Ceramic
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Metallic
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Polymers
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Natural
9.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Implantable Medical Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)
Chapter 11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Biotronik SE & Co. KG
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Boston Scientific Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. C. R. Bard, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Cardinal Health, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. CONMED Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Globus Medical, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Integra Lifesciences Holdings Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Johnson & Johnson
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. LivaNova PLC
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1430
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
More Articles:
- Energy Efficient Lighting Technology Market Size is Forecasted to Reach US$ 406.44 billion by 2030
- Biopharmaceutical Market Size is Predicted to Reach US$ 856.1 billion by 2030
- Respiratory Monitoring Devices Market To Reach Valuation of US$ 2.95 Bn By 2030
- Home Diagnostics Market Size is Forecasted to Reach US$ 8.15 billion by 2030
- US Dental Services Market Size is Forecasted to Reach US$ 196.18 billion by 2027
- Commercial Display Market Trending Technologies with 5.8% of CAGR by 2030
- Solar Vehicle Market to Grow Nearly 32.2% through 2030 | Potential Opportunity Is Opening in the Coming Years
- Healthcare Information Systems Market Size is Forecasted to Reach US$ 528.5 Bn by 2030
- PACS and RIS Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2030
